Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

24 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Non-neurological, non-skeletal outcomes after hematopoietic stem and progenitor cell-gene therapy (OTL-203) for Hurler syndrome.
Tucci F, Uria Oficialdegui ML, Consiglieri G, Cossutta M, Filisetti C, Fumagalli F, Butera C, Santangelo R, Colombo M, Manitto MP, Stoppani M, Martina E, Danè G, Camesasca C, Risca G, De Pellegrin M, Scarparo S, Sarzana M, Puricelli C, Galimberti S, Darin S, Silvani P, Bonanomi S, Gasperini S, Naldini L, Gentner B, Parini R, Del Toro M, Diaz-de-Heredia C, Aiuti A, Bernardo ME. Tucci F, et al. Among authors: cossutta m. Mol Ther. 2025 Sep 27:S1525-0016(25)00814-7. doi: 10.1016/j.ymthe.2025.09.042. Online ahead of print. Mol Ther. 2025. PMID: 41017152
New standards in HER2-low testing: the CASI-01 comparative methods study.
Dabbs DJ, Torlakovic E, Nielsen S, Parry SC, Yu J, Stoos C, Clark B, Høeg H, Thagaard J, Sompuram SR, Naber SP, Yagi Y, Sayre J, Vani K, Cossutta M, Soussaline F, Papine A, t'Hart NA, Szabolcs MJ, Jasani B, Kinloch M, Chiriboga L, Miller K, Bogen S. Dabbs DJ, et al. Among authors: cossutta m. EBioMedicine. 2025 Oct;120:105919. doi: 10.1016/j.ebiom.2025.105919. Epub 2025 Sep 12. EBioMedicine. 2025. PMID: 40945049 Free article.
Correction: Ponzo et al. Nucleolin Therapeutic Targeting Decreases Pancreatic Cancer Immunosuppression. Cancers 2022, 14, 4265.
Ponzo M, Debesset A, Cossutta M, Chalabi-Dchar M, Houppe C, Pilon C, Nicolas-Boluda A, Meunier S, Raineri F, Thiolat A, Nicolle R, Maione F, Brundu S, Cojocaru CF, Bouvet P, Bousquet C, Gazeau F, Tournigand C, Courty J, Giraudo E, Cohen JL, Cascone I. Ponzo M, et al. Among authors: cossutta m. Cancers (Basel). 2022 Dec 14;14(24):6160. doi: 10.3390/cancers14246160. Cancers (Basel). 2022. PMID: 36551754 Free PMC article.
Nucleolin Therapeutic Targeting Decreases Pancreatic Cancer Immunosuppression.
Ponzo M, Debesset A, Cossutta M, Chalabi-Dchar M, Houppe C, Pilon C, Nicolas-Boluda A, Meunier S, Raineri F, Thiolat A, Nicolle R, Maione F, Brundu S, Cojocaru CF, Bouvet P, Bousquet C, Gazeau F, Tournigand C, Courty J, Giraudo E, Cohen JL, Cascone I. Ponzo M, et al. Among authors: cossutta m. Cancers (Basel). 2022 Aug 31;14(17):4265. doi: 10.3390/cancers14174265. Cancers (Basel). 2022. PMID: 36077801 Free PMC article.
24 results